S&P 500 Consumer Staples Sector SEC Filings — March 10, 2026

10-03-2026

Elevance Health, Inc. reaffirmed its FY2026 adjusted shareholders’ earnings guidance at least $25.50 per diluted share and benefit expense ratio of 90.2% plus or minus 50 basis points, incorporating the potential impact of CMS sanctions. These sanctions, notified on February 27, 2026, would suspend Medicare Advantage-Prescription Drug plan enrollments and certain communications effective March 31, 2026, unless resolved. The guidance reflects confidence despite this regulatory risk.

• ·CMS notified Company of sanctions intent on February 27, 2026, as reported in prior 8-K filed March 2, 2026
• ·Sanctions effective March 31, 2026, unless issues addressed
• ·No GAAP reconciliation provided for adjusted EPS guidance due to uncertain financial payments related to sanctions

10-03-2026

Aclaris Therapeutics, Inc. sold 12.7 million shares of its common stock for aggregate gross proceeds of $39.8 million from March 2, 2026, through March 9, 2026, pursuant to its amended and restated sales agreement with Leerink Partners LLC and Cantor Fitzgerald & Co. The shares were purchased by institutional investors, including Deep Track Capital. No other financial metrics or period-over-period comparisons were disclosed.

• ·Sales occurred from March 2, 2026, through March 9, 2026
• ·Information under Item 7.01 is not deemed 'filed' for liability purposes per General Instruction B.2.

10-03-2026

Climate Transition Special Opportunities SPAC I, a Cayman Islands blank check company targeting mergers in climate transition, specialty finance, renewable energy, and regenerative agriculture sectors, filed Amendment No. 3 to its S-1 registration statement for a $150M IPO of 15M units at $10 each, consisting of one Class A ordinary share and one-third of a redeemable warrant exercisable at $11.50. Net proceeds before expenses are $141M, with $150M (or $172.5M if over-allotment exercised) to be placed in trust; sponsor holds 5,675,000 founder shares after share split and transfers. No target identified yet, and investing involves high risks as noted in the prospectus.

• ·Warrants exercisable 30 days after initial business combination, expire 5 years post-combination
• ·Underwriting over-allotment option: 45 days from prospectus date
• ·Separate trading of shares and warrants expected on 52nd day post-prospectus
• ·NYSE listing intended: CLSO U (units), CLSO (shares), CLSO WS (warrants)
• ·Sponsor transferred 25,000 founder shares to each independent director (total 75,000) at ~$0.004/share

10-03-2026

Belpointe PREP, LLC, through its indirect subsidiary BPOZ 100 Tokeneke Holding, LLC, entered into a $5M convertible promissory note at 3.6% interest, due March 3, 2028, with 100 Tokeneke Road, LLC to fund the purchase of real property at 100 Tokeneke Road, Darien, Connecticut. Concurrently, Belpointe Tokeneke Investment, LLC—a related party indirectly owned by family members of CEO Brandon E. Lacoff—provided a $3.25M loan on similar terms, including a mandatory $0.625M conversion granting it 50% ownership in 100 Tokeneke Partners, LLC. The transactions were approved by the Company's Conflicts Committee in compliance with related party policies.

• ·Loan origination date: March 3, 2026
• ·Loan maturity date: March 3, 2028
• ·Property address: 100 Tokeneke Road, Darien, Connecticut
• ·Filing is Amendment No. 1 to correct scrivener’s error on maturity dates in initial 8-K filed March 9, 2026

10-03-2026

York Space Systems Inc. (YSS) entered into a Merger Agreement on March 6, 2026, to acquire all issued and outstanding equity interests of Orbion Space Technology, Inc. in exchange for cash and 2,812,141 shares of YSS common stock. The shares, subject to transfer restrictions, were issued under a Section 4(a)(2) exemption from Securities Act registration requirements.

• ·Merger involves Orbion sellers’ representative.
• ·Filing signed March 9, 2026; reported under Item 3.02 Unregistered Sales of Equity Securities.

10-03-2026

Kohl’s reported Q4 FY2025 net sales of $5.0B, down 3.9% YoY with comparable sales down 2.8%, while full-year net sales fell 4.0% to $14.8B with comparable sales down 3.1%; however, operating income rose to $212M in Q4 (from $126M) and $624M full-year (from $433M), driven by gross margin expansion and SG&A reductions. Adjusted diluted EPS improved to $1.07 in Q4 and $1.62 full-year, with strong cash flow from operations at $750M in Q4 and $1.4B full-year. The company introduced FY2026 guidance for net sales down 2% to flat and share repurchases via dividend of $0.125/share.

• ·Borrowings under revolving credit facility reduced to $0 from $290M YoY.
• ·FY2026 guidance: Adjusted operating margin 2.8% to 3.4%; Adjusted diluted EPS $1.00 to $1.60; Capex $350M to $400M.
• ·Quarterly dividend $0.125 per share, payable April 1, 2026 to shareholders of record March 18, 2026.
• ·Cash and equivalents increased to $674M from $134M.

10-03-2026

Stagwell Inc. reported FY25 revenue growth of 2% YoY to $2.91B and net revenue growth of 6% to $2.43B, with stronger ex-Advocacy net revenue up 9% to $2.28B driven by Digital Transformation (+13%) and Marketing Cloud (+230%); however, overall Adjusted EBITDA grew modestly 1% to $422M, reflecting tempered performance including flatish Advocacy contributions. Free cash flow more than doubled to $187M, net new business reached $476M LTM, and the company announced a $350M increase to its stock repurchase program ($400M available). 2026 guidance projects net revenue growth of 8-12% and Adjusted EBITDA of $475-525M.

• ·Q4 Adjusted EBITDA margin of 20% on net revenue; FY25 Adjusted EBITDA margin of 17% on net revenue.
• ·Repurchase Program expires March 4, 2029; previously approved program extended.
• ·2026 guidance: Adjusted EPS of $0.98 - $1.12; Free Cash Flow Conversion of 50% to 60%.
• ·Video webcast on March 10, 2026 at 8:30 a.m. (ET).

10-03-2026

Domo reported Q4 FY26 total revenue of $79.6 million, up 1% YoY, with subscription revenue increasing 2% to $73.4 million and billings reaching a record $111.2 million (+8% YoY), while current subscription RPO grew only 1% to $227.0 million. Full-year FY26 revenue rose 1% to $318.9 million, billings increased 3% to $318.7 million, and non-GAAP operating margin improved to 10% in Q4 (from 4%) and 6% FY (from -1%), but GAAP net loss was $8.0 million in Q4 and $59.3 million FY amid flat overall growth. Operating cash flow turned positive at $7.9 million FY (up $17 million YoY), though adjusted free cash flow remained negative at $0.6 million.

• ·Q4 FY26 GAAP operating margin -13% (improved 2pp YoY); FY26 GAAP operating margin -12% (improved 6pp YoY)
• ·Q4 FY26 non-GAAP net income $1.2M ($0.03/share diluted); FY26 non-GAAP net loss $1.3M ($0.03/share)
• ·FY26 adjusted free cash flow -$0.6M (improved $12.3M YoY)
• ·Cash and cash equivalents declined to $43.0M from $45.3M as of Jan 31, 2025
• ·Earnings conference call held March 10, 2026 at 3:00 p.m. MT / 5:00 p.m. ET

10-03-2026

Pebblebrook Hotel Trust announced on March 10, 2026, that it will report its Q1 2026 financial and operating results after market close on April 28, 2026, followed by a conference call on April 29, 2026, at 9:00 AM ET. The company, a REIT owning 44 hotels with approximately 11,000 guest rooms across 13 urban and resort markets, provided dial-in and webcast details for the call. Raymond D. Martz, Co-President and CFO, is listed as the contact.

• ·Conference call dial-in: +1 (877) 407-3982
• ·Live webcast and replay available at www.pebblebrookhotels.com
• ·Securities: Common Shares (PEB), Series E (PEB-PE), F (PEB-PF), G (PEB-PG), H (PEB-PH) on NYSE

10-03-2026

The Clorox Company entered into a 364-day revolving credit agreement dated March 6, 2026, with banks including JPMorgan Chase Bank, N.A., Citibank, N.A., and Wells Fargo Bank, National Association as administrative agents, to support its acquisition of GOJO Industries, Inc. The acquisition is governed by a Membership Interest Purchase Agreement dated January 17, 2026. No specific commitment amounts or pricing details are provided in the filing excerpt.

• ·Filing date: March 10, 2026
• ·Credit agreement maturity: 364 days from March 6, 2026
• ·SEC items reported: 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 9.01 (Financial Statements and Exhibits)

10-03-2026

Reliance Global Group, Inc. reported a net loss of $7.0M for the year ended December 31, 2025, an improvement of 23% YoY from $9.1M in 2024, primarily due to a $3.2M gain on the sale of businesses including Fortman Insurance Services (FIS), Employee Benefits Solutions (EBS), and U.S. Benefits Alliance (USBA). However, commission income declined 12% YoY to $12.4M amid these portfolio realignments, loss from operations worsened 17% to $9.0M, total operating expenses were nearly flat at a 1% decrease to $21.4M, and AEBITDA deteriorated sharply 397% to $(1.6M). Cash flows showed a net increase of $0.9M, reversing a $0.9M decrease in 2024, supported by $5.3M from investing activities.

• ·Salaries and wages increased 43% YoY to $10.3M, driven by non-cash share-based compensation.
• ·Equity-based compensation totaled $5.7M in 2025, up significantly from $0.9M in 2024.
• ·Net cash used in operating activities increased to $3.1M from $2.5M YoY.
• ·Asset sales contributed to $5.3M net cash from investing activities in 2025.

10-03-2026

Motorsport Games Inc. reported strong Q4 2025 revenue growth to $3.8M (up 94.9% YoY from $2.0M) and FY 2025 revenue of $11.3M (up 30.0% YoY from $8.7M), driven by $5.8M increase in Le Mans Ultimate sales and $1.2M from RaceControl, achieving FY net income of $6.8M and Adjusted EBITDA of $7.3M versus prior losses. However, revenues were offset by a $4.4M decline from divested NASCAR titles, with no sponsorship or events revenue from the Esports segment in 2025 or 2024 due to no Le Mans Virtual Series. Cash from operations reached $4.1M for FY 2025, with year-end cash at $5.0M increasing to $6.0M by February 2026, bolstered by a $3M Citibank revolving credit line.

• ·Average concurrent players on Steam grew more than fivefold through 2025.
• ·Q4 2025 Adjusted EBITDA of $1.9M vs. loss of $2.5M in Q4 2024.
• ·FY 2025 EPS of $1.43 vs. -$0.94 in FY 2024.
• ·Gaming segment represented 100% of revenues in both FY 2025 and 2024; no Le Mans Virtual Series event organized.

10-03-2026

Oracle reported exceptional Q3 FY26 results with total revenue of $17.2B, up 22% YoY in USD and 18% in constant currency, driven by cloud revenue of $8.9B up 44% in USD and 41% in constant currency, including IaaS at $4.9B up 84%. However, software revenues grew only 3% in USD and declined 1% in constant currency to $6.1B, while hardware revenues increased 2% in USD but fell 2% in constant currency. Remaining Performance Obligations surged 325% YoY to $553B, GAAP EPS rose 24% to $1.27, and non-GAAP EPS increased 21% to $1.79.

• ·Quarterly dividend declared at $0.50 per share, record date April 9, 2026, payment date April 24, 2026.
• ·Raised $30B in investment grade bonds and mandatory convertible preferred stock.
• ·Q4 FY26 guidance: Total revenue 19-21% USD growth; Cloud revenue 46-50% USD growth; Non-GAAP EPS $1.96-$2.00 USD.
• ·Q3 GAAP operating income $5.5B up 25% YoY USD; Non-GAAP operating income $7.4B up 19% YoY USD.

10-03-2026

Net sales declined 9.5% YoY to $273.8M in 2025 from $302.4M in 2024, primarily due to a 38% drop in medium and heavy-duty truck revenue ($101.3M) and 7% decline in power sports ($63.5M), though building products grew 32% to $22.5M and industrial/utilities rose 20% to $22.6M. Net income fell 15.8% to $11.2M amid higher costs, while total assets expanded 8.8% to $228.1M supported by capex. Operating cash flow decreased 45% to $19.2M, with significant $13.8M in capital expenditure commitments.

• ·Gross margin $47.6M in 2025, down from $53.3M in 2024.
• ·Capex purchases $17.3M in 2025, up from $11.5M in 2024.
• ·Treasury stock purchases totaled $3.2M in 2025.
• ·Post-retirement benefits liability $3.1M as of Dec 31 2025.

10-03-2026

Invesco Mortgage Capital Inc. (NYSE: IVR) appointed Stephanie J. Larosiliere, a veteran fixed income expert with over two decades of experience and current Head of Business Strategy and Development for Invesco Ltd. Fixed Income in North America & APAC, to its Board of Directors as an executive director, effective March 6, 2026. The appointment is intended to strengthen stockholder engagement, alignment, and institutional investor relations. Don Liu, Chair of the Board, emphasized her expertise in fixed income markets and ability to identify emerging trends.

• ·Company is a real estate investment trust externally managed by Invesco Advisers, Inc.
• ·Investor Relations Contact: Gregory Seals, 404-439-3323
• ·Website: www.invescomortgagecapital.com

10-03-2026

ClearSign Technologies Corporation amended its Certificate of Incorporation to authorize 89.5M shares of capital stock, consisting of 87.5M shares of common stock and 2M shares of preferred stock, each with a par value of $0.0001 per share. The amendment implements a 1-for-10 reverse stock split effective 12:01 a.m. ET on March 16, 2026, converting every 10 outstanding shares of old common stock into 1 share of new common stock without changing the total authorized shares. No fractional shares will result in cash payments; instead, they will be rounded up to the nearest whole share.

• ·Reverse stock split ratio: 1-for-10
• ·Original Certificate filed June 14, 2023; previously amended June 25, 2024
• ·Amendment adopted per Section 242 of Delaware General Corporation Law
• ·Signed March 6, 2026

10-03-2026

Kodiak AI announced Q4 and FY 2025 results, with revenue of $1.1M reflecting 37% QoQ growth, deployments expanding to 20 fully driverless trucks (100% QoQ increase from 10), and cumulative paid driverless operations reaching over 10,700 hours (106% QoQ increase). However, the company reported net cash used in operating activities of $24.2M and negative free cash flow of $34M, though better than guided negative $36-38M range. Balance sheet strengthened to $120.7M in cash, cash equivalents, and marketable securities after a $30M debt refinancing.

• ·Deployed 10 additional trucks to Atlas Energy Solutions.
• ·Introduced capability to pull three trailers with one tractor.
• ·Announced collaboration with Bosch for next-generation platform.
• ·Launched Dallas-Fort Worth to El Paso route and new Dallas-Houston pilot.
• ·Upcoming: JP Morgan Industrials Conference on March 17, 2026.

10-03-2026

CVG reported Q4 2025 revenue of $154.8 million, down 5.2% YoY from $163.3 million due to softer North American demand, and full-year 2025 revenue of $649.0 million, down 10.3% YoY from $723.4 million. Despite revenue declines, operating losses improved (Q4 to $1.8 million from $5.3 million), adjusted EBITDA rose 155.6% to $2.3 million in Q4, free cash flow reached $34.0 million for the full year (up $21.5 million), and debt decreased $29.1 million; however, Trim Systems and Components revenue fell 22.5% YoY while Global Electrical Systems grew 12.7%. The company named as Zoox Robotaxi low voltage wire harness strategic supplier and provided 2026 outlook of $660-700 million in net sales and $24-30 million adjusted EBITDA.

• ·Q4 2025 adjusted operating loss of $0.9 million, improved from $4.3 million in Q4 2024.
• ·Full year 2025 SG&A expenses declined $4.8 million YoY.
• ·As of Dec 31, 2025: $16.8 million U.S. revolver borrowings, $1.4 million China facility borrowings, $101.8 million availability.
• ·2026 outlook: Positive free cash flow; Construction end market low-single digit growth.

10-03-2026

CleanCore Solutions, Inc. (ZONE) terminated its Asset Management Agreement with Dogecoin Ventures, Inc. (a subsidiary of House of Doge Inc.) and 21Shares US LLC, originally entered on September 5, 2025, by transferring 70,000,000 Dogecoin tokens (61,250,000 to DCV and 8,750,000 to 21Shares) and providing mutual releases. The company also terminated its executive consulting agreement with Marco Margiotta, paying him $500,000 cash, leading to his resignation as Chief Investment Officer effective March 4, 2026. No financial performance metrics or period-over-period comparisons were disclosed.

• ·Asset Management Agreement termination effective March 6, 2026 (Agreement of Termination dated March 9, 2026)
• ·Consulting Agreement termination effective March 4, 2026
• ·Previous agreements dated September 5, 2025, as disclosed in prior 8-K
• ·Certain provisions survive Asset Management Agreement termination: Section 11 (Liability and Indemnification), Section 12 (Confidentiality), Section 16(i) (Arbitration)

10-03-2026

Wheels Up Experience Inc. reported 2025 revenue of $737M, down 7% YoY from $792M, while cost of revenue declined 10% to $663M. Net loss improved 13% to $294M from $340M, with Adjusted EBITDA advancing to -$43M from -$118M and gross margin expanding to 1.7% from 0.3%; Adjusted Contribution Margin rose to 14.1% from 10.8%. However, cash and equivalents fell to $134M from $216M, total assets decreased to $969M from $1.16B, and net cash used in operating activities worsened to $166M from $78M.

• ·Gain on sale of aircraft held for sale: $52M in 2025 vs $4.6M in 2024.
• ·Interest expense increased 38% to $90M.
• ·Long-term debt, net: $316M at Dec 31, 2025 vs $376M at Dec 31, 2024.
• ·Deferred revenue, current: $739M at Dec 31, 2025 vs $749M at Dec 31, 2024 (slight decline).
• ·Net cash provided by investing activities: $180M in 2025 vs -$47M in 2024.

10-03-2026

NewtekOne, Inc. reported net income of $60.5M for the year ended December 31, 2025, up 19% YoY from $50.9M, supported by net interest income after provisions rising 50% to $21.2M and noninterest income increasing 3.5% to $224.9M. However, provision for credit losses surged 48% to $38.7M due to deteriorating credit quality, with nonaccrual loans at amortized cost climbing to 8.8% ($78.8M) from 3.9% ($24.3M) and total nonperforming assets reaching 5.8% of total assets from 4.6%. Noninterest expenses also rose 2.1% to $166.1M.

• ·Loans HFI at amortized cost grew to $894.3M from $620.4M YoY.
• ·Average interest-earning assets increased to $1.99B from $1.40B, but net interest margin improved slightly to 3.01% from 2.87%.
• ·Total goodwill and intangibles decreased slightly to $14.6M from $14.8M.
• ·NTS sold to IPM on January 2, 2025; NCL merged into NALH on May 13, 2025.

10-03-2026

ADM announced the appointment of Michael McMurray, former executive vice president and CFO of LyondellBasell Industries N.V., to its Board of Directors, effective March 9, 2026. McMurray, with over three decades of financial and strategic leadership experience from roles at Owens Corning and Royal Dutch Shell, will serve on the Audit and Sustainability and Technology committees. Board Chair and CEO Juan Luciano praised McMurray's expertise in finance, international business, strategy, and M&A as aligning with ADM's growth opportunities.

• ·McMurray holds a bachelor’s degree in Business Administration from Trinity University and an MBA from Tulane University.
• ·McMurray currently serves on the boards of Flowserve Corporation and the Children’s Advocacy Centers of Texas.

10-03-2026

Beeline Holdings, Inc. filed a prospectus supplement on March 10, 2026, registering up to $15M of common stock for at-the-market sales under an existing agreement with Ladenburg Thalmann & Co., Inc., following prior sales of approximately 5,907,698 shares for $8.26M in gross proceeds. Ladenburg will receive 3.0% commission on new sales. No sales have occurred under the new supplement yet.

• ·Agreement originally dated April 30, 2025; prior 8-K filed May 1, 2025
• ·Registration Statement on Form S-3 (File No. 333-284723)
• ·Sales methods include direct on Nasdaq, to market makers, or negotiated to Ladenburg

10-03-2026

Delek US Holdings, Inc. released its DEF 14A Proxy Statement for the 2026 Annual Meeting of Stockholders on April 20, 2026, at 11:30 a.m. CT, virtually via www.virtualshareholdermeeting.com/DK2026, with proposals to elect ten directors, adopt an advisory resolution on executive compensation, approve the 2026 Long-Term Incentive Plan, and ratify Ernst & Young LLP as auditors for fiscal 2026. The record date is February 27, 2026, when 59,808,421 shares of Common Stock were outstanding. The Board unanimously recommends voting 'FOR' all proposals.

• ·Proxy materials first available on or about March 9, 2026
• ·Voting by internet/phone closes at 11:59 p.m. ET on April 19, 2026
• ·Stockholders of record as of February 27, 2026 close of business eligible to vote

10-03-2026

BriaCell Therapeutics Corp. reported a widened net loss of $15.6M for the six months ended January 31, 2026, up 28% YoY from $12.2M, primarily due to R&D expenses rising 36% to $12.7M while G&A remained relatively flat. Cash and equivalents increased significantly to $29.9M from $10.5M at July 31, 2025, supported by $27.9M in net financing proceeds from unit issuance, driving total assets to $33.6M. However, operating cash burn intensified to $15.7M and the company notes substantial doubt on going concern due to ongoing losses and accumulated deficit of $127.2M.

• ·Warrant liability decreased to $195K from $338K.
• ·Equity investment in BC Therapeutics increased to $582K from $524K.
• ·Current liabilities decreased to $3.2M from $4.0M.
• ·Shares increased via issuance of 4.3M units and exercise of 1.0M warrants.

10-03-2026

10-03-2026

Clean Energy Technologies, Inc. entered into a Securities Purchase Agreement dated March 4, 2026, with 1800 Diagonal Lending LLC to issue and sell a promissory note with an aggregate principal amount of $147,840, including $15,840 of Original Issue Discount, for a net purchase price of approximately $132,000. The closing occurred on or about March 5, 2026, under exemptions from SEC registration requirements. The note is convertible into common shares, with the company having 2,000,000,000 authorized shares and 12,166,106 outstanding as of the agreement date.

• ·Agreement relies on exemptions under the Securities Act of 1933.
• ·Buyer is an accredited investor purchasing for investment purposes.
• ·No material adverse changes since September 30, 2025, per company representations.

10-03-2026

Fidelity National Information Services, Inc. (FIS) completed the closing of its USD-denominated senior notes offering on March 10, 2026, issuing $2B of 4.450% notes due 2028, $2.3B of 4.550% notes due 2029, $500M of floating rate notes due 2029, and $2B of 4.800% notes due 2031, for a total of $6.8B. Simultaneously, FIS closed its Euro-denominated senior notes offering, issuing €500M of floating rate notes due 2028 and €500M of 3.450% notes due 2030, for a total of €1B. The offerings were conducted under previously filed underwriting agreements and indentures with trustees Regions Bank and U.S. Bank Trust Company.

• ·Underwriting agreements dated March 4, 2026 (USD Notes) and March 5, 2026 (Euro Notes).
• ·Indentures dated March 10, 2026, with Regions Bank (USD Notes portions) and U.S. Bank (other portions).
• ·Offered pursuant to S-3 Registration Statement (File No. 333-288198) filed June 20, 2025, amended February 26, 2026.
• ·Legal opinions provided by Willkie Farr & Gallagher LLP and Troutman Pepper Locke LLP.

10-03-2026

Pulmonx Corp (LUNG) reported FY2025 revenue of $90.5M, up 8.0% YoY from $83.8M, with gross profit rising 8.3% to $67.1M and operating loss narrowing 7.0% to $(53.7M) amid a 0.9% increase in total operating expenses. Net loss improved 4.2% YoY to $(54.0M) from $(56.4M), driven by higher other income, but SG&A expenses were nearly flat down 0.8%, interest income dropped 47.6%, and stockholders' equity fell sharply to $54.1M from $85.8M due to accumulated deficit growth. Cash and equivalents slightly declined to $69.8M, with net cash used in operations worsening marginally to $(32.4M).

• ·Total assets declined to $129.3M from $162.9M YoY.
• ·Long-term debt increased to $37.0M from $34.0M.
• ·Stock-based compensation expense decreased to $21.1M from $23.0M.
• ·Net cash provided by investing activities rose to $30.5M from $17.5M.
• ·Cash, cash equivalents, and restricted cash at year-end: $70.0M (2025) vs $71.2M (2024).

10-03-2026

ExxonMobil filed a DEFA14A additional proxy statement on March 10, 2026, referencing its 10-K for the year ended December 31, 2025 (filed February 18, 2026), a preliminary proxy statement filed the same day, and other SEC filings. No new financial data, metrics, or material updates are provided in this filing.

10-03-2026

Prelude Therapeutics reported FY2025 financial results with revenue increasing 73% YoY to $12.1M from $7.0M, R&D expenses decreasing 20% to $94.3M from $118.0M, and G&A expenses falling 22% to $22.4M from $28.7M, leading to a reduced net loss of $99.5M ($1.29/share) versus $127.2M ($1.68/share) in FY2024; however, the company remains unprofitable with total assets declining to $141.3M from $175.5M. Cash, cash equivalents, restricted cash, and marketable securities stood at $106.4M as of December 31, 2025, providing a runway into Q2 2027. Pipeline progress includes FDA IND clearance for PRT12396 (Phase 1 initiation in Q2 2026) and planned IND filing for PRT13722 in mid-2026.

• ·Stock-based compensation in R&D: $6.9M in FY2025 vs $12.1M in FY2024
• ·Stock-based compensation in G&A: $5.0M in FY2025 vs $9.2M in FY2024
• ·Deferred revenue: $33.7M current + $1.8M non-current as of Dec 31, 2025
• ·JAK2V617F mutation impacts 95% PV, 60% ET, 55% MF patients
• ·mCALR found in 25-35% of MF and ET patients
• ·Participation in Citizens Life Sciences Conference fireside chat on March 10, 2026 at 3:25 PM ET

10-03-2026

Moog Inc. announced its intention to offer $500 million aggregate principal amount of senior notes due 2034, subject to market and customary conditions. The company plans to use the net proceeds from the offering, along with cash on hand, to redeem all $500 million of its outstanding 4.250% Senior Notes due 2027, including accrued and unpaid interest. The announcement includes a preliminary offering memorandum furnished under Regulation FD, with forward-looking statements noting risks and uncertainties.

• ·Notes due 2034 and 2027 Notes; offering not registered under Securities Act
• ·Class A common stock (MOG.A) and Class B common stock (MOG.B) registered on New York Stock Exchange

10-03-2026

Welltower OP LLC, a subsidiary of Welltower Inc., entered into an Amended and Restated Credit Agreement on March 6, 2026, establishing a $6.25B unsecured revolving credit facility, replacing the prior $5B revolving facilities plus $1B USD and CAD 250M term loans. The new facility includes a $4.25B Revolving A Tranche maturing March 6, 2030, and a $2B Revolving B Tranche maturing July 24, 2029, with potential expansion up to $1.25B. Interest and fees are tied to debt ratings and sustainability metrics, with no reported declines in capacity.

• ·Revolving A Tranche extendable by two successive 6-month terms upon payment of 0.0625% fee if no default.
• ·Interest based on base rate or SOFR plus margin tied to debt ratings; quarterly facility fee also rating-based.
• ·Sublimits part of, not additional to, Revolving Facility totals.
• ·Agreement includes customary covenants, representations, warranties, and events of default.

10-03-2026

Worthington Steel lowered the minimum acceptance threshold for its voluntary takeover offer for Kloeckner & Co SE to 57.5% after securing approximately 56.9% of shares as of March 9, 2026, extending the acceptance period to March 26, 2026, while keeping the offer price at €11.00 per share (98% premium to undisturbed three-month VWAP as of December 5, 2025). Kloeckner's Management and Supervisory Boards deem the offer attractive and recommend acceptance. However, consummation remains subject to meeting the new threshold, with risks including potential shareholder withdrawals and regulatory approvals.

• ·Offer intention announced January 15, 2026; offer phase started February 5, 2026.
• ·Kloeckner supplies more than 60,000 customers primarily in North America and DACH region (Germany, Austria, Switzerland).
• ·Offer documents available at www.strong-for-good.com.

10-03-2026

Marsh announced Nick Studer as the new President and CEO of Marsh Risk effective April 1, 2026, succeeding Martin South, who transitions to Chief Client Officer in an enterprise-wide role; both will report to John Doyle, President and CEO of Marsh, and remain on the Executive Committee. The changes aim to accelerate growth, enhance client value, and leverage AI and technologies. Marsh, with annual revenue over $27B and more than 95,000 colleagues across 130 countries, expects to announce new CEOs for Oliver Wyman and Marsh Management Consulting by April 1.

• ·Nick Studer joined Oliver Wyman in 1997 and became its CEO in 2021.
• ·Martin South rejoined Marsh in 2007, previously served as CEO of Marsh Risk since 2022, and held roles at Zurich Financial Services.

10-03-2026

TKO Group Holdings, Inc. announced $1B in share repurchases, consisting of an $800M accelerated share repurchase (ASR) agreement with Morgan Stanley & Co. LLC and a 10b5-1 trading plan for up to $200M, utilizing its existing $2B authorization. Under the ASR, TKO will pay $800M on March 11, 2026, for an initial delivery of 3,136,179 Class A common shares, with final settlement in June 2026. President and COO Mark Shapiro highlighted this as a reflection of confidence in TKO's business and commitment to shareholder value.

• ·10b5-1 Plan repurchases to commence after ASR completion.
• ·TKO's businesses include UFC, WWE, PBR, Zuffa Boxing (joint venture), IMG, and On Location.

10-03-2026

On March 6, 2026, Sean Steves notified Casella Waste Systems, Inc. of his resignation as Senior Vice President and Chief Operating Officer of Solid Waste Operations, effective March 20, 2026, to pursue opportunities outside the waste and recycling industry. The departure was not due to any disagreement with the company's operations, policies, or practices. The company has initiated a search for a replacement.

• ·Filing date: March 10, 2026
• ·Date of earliest event reported: March 6, 2026

10-03-2026

NEXGEL, Inc. signed a definitive agreement to license and acquire a portfolio of 6 commercial-stage regenerative biomaterial products from Celularity Inc., expected to triple annual revenue to about $35 million and make the company immediately profitable upon closing. The deal includes an experienced commercial team and three new 510(k) filings planned for 2026, 2027, and 2028, with closing anticipated in Q1 or early Q2 2026 subject to $14.9 million in additional financing. No historical performance declines or flat metrics are disclosed in the filing.

• ·Portfolio focused on tendon repair, skin grafts, and bone growth with over a decade of clinical use and existing insurance reimbursement.
• ·Palladium Capital Group, LLC acted as placement agent on the financing.
• ·Further details to be filed in a subsequent Form 8-K.

10-03-2026

KDP Coffee Co., the coffee segment of Keurig Dr Pepper Inc., reported FY2025 net sales of $4.7B, up 1% YoY from $4.6B but down 2% from FY2023's $4.8B, with net income declining 5% YoY to $700M due to higher cost of sales and lower gross profit (down 7% to $1.9B). Operating cash flow improved significantly to $629M from $459M, while inventories surged 45% to $954M. These audited combined financial statements support KDP's planned Q2 2026 acquisition of JDE Peet’s and subsequent spin-off of the combined coffee business into Global Coffee Co.

• ·Cash and cash equivalents increased to $168M as of Dec 27, 2025 from $132M.
• ·Property, plant, and equipment, net rose to $944M from $866M.
• ·Intangible assets, net declined to $2,951M from $3,045M due to amortization.
• ·Net cash used in investing activities improved to $162M from $241M.
• ·Net transfers to Parent were $329M in FY2025.

10-03-2026

Celularity Inc. entered a strategic commercialization partnership licensing its placental-derived biomaterials portfolio, expected to generate up to $35M in non-dilutive upfront and milestone payments plus royalties, while retaining exclusive manufacturing rights for ongoing revenue. The deal includes organizational realignment with personnel transitions to the partner and workforce reductions to lower operating expenses and sharpen focus on longevity therapeutics. Transaction is set to close no later than April 15, 2026.

• ·Exclusive manufacturing at FDA-compliant facility in Florham Park, New Jersey
• ·Expanded commercial and clinical opportunities in Florida, Texas, and Arizona under state investigational use frameworks
• ·pH Partners, LLC acted as financial advisor

10-03-2026

On February 24, 2026, Brian Coad resigned from the Board of Directors of Piermont Valley Acquisition Corp, with the resignation explicitly stated as not resulting from any disagreement on the Company's operations, policies, or practices. The 8-K filing was submitted on March 10, 2026, and signed by Wei Qian, Chairman and Chief Executive Officer. No replacement director or officer was announced.

10-03-2026

Horizon Technology Finance Corporation (HRZN) announced its intent to supplement regular monthly distributions using $27.6M in undistributed taxable earnings (spillover income) as of December 31, 2025, providing at least $0.02 to $0.04 per share per month for two quarters post-merger with Monroe Capital Corporation (MRCC). MRCC plans to increase its final special distribution by $13.0M ($0.61 per share), in addition to a $2.9M ($0.14 per share) tax distribution from asset sale proceeds to Monroe Capital Income Plus Corporation (MCIP). These enhancements aim to create near-term value for combined company stockholders, subject to merger closing and board approval.

• ·HRZN special meeting of stockholders scheduled for March 13, 2026, at 2:30 p.m. ET.
• ·Distributions subject to asset coverage ratios, financial covenants, investment performance, liquidity, and market conditions.

10-03-2026

Travel + Leisure Co. posted new written investor presentation materials on its investor relations website (investor.travelandleisureco.com) on March 9, 2026, for use in meetings with the investment community and general marketing purposes. The company noted it may use its website and LinkedIn for disclosing material information. This information under Item 7.01 is not deemed 'filed' under the Exchange Act.

• ·Materials posted for Regulation FD compliance and not subject to Section 18 liabilities of the Exchange Act.
• ·Investors advised to monitor IR website and LinkedIn for material disclosures.